Avoro News

Avoro Capital Updates

We are pleased to share industry insights and updates on Avoro and our portfolio companies. Please reach out if you would like to learn more.

Apellis Pharmaceuticals Announces $60 Million Series E Financing

Funding Will Advance Trials of APL-2 in Paroxysmal Nocturnal Hemoglobinuria LOUISVILLE, KY., August 10, 2017 – Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, today announced the closing of a $60 million Series E preferred stock financing led by Sectoral Asset Management. New …

Read More

Fennec Announces $7.6 Million Private Placement of Common Shares Led by venBio Select Advisor

Fennec Announces $7.6 Million Private Placement of Common Shares Led by venBio Select Advisor RESEARCH TRIANGLE PARK, NORTH CAROLINA — (Marketwired) — 06/08/17 — Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) (the “Company” or “Fennec”), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced chemotherapy ototoxicity in pediatric …

Read More

LATEST
202120202018201720152014